This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. (Novartis via AP) NEW YORK (AP) — Researchers on Wednesday reported ...

LONDON (Reuters) -A new antimalarial drug developed by Novartis is as effective as existing treatments and could help tackle rising drug resistance, the company said on Wednesday as it presented final ...

Nigeria’s fight against malaria may be entering a more dangerous phase as scientists reveal a new urban mosquito species and rising drug and insecticide resistance could reverse years of progress if ...

Researchers analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance. Researchers at University of California San Diego ...

Scientists from Drexel University’s College of Medicine and Columbia University’s Irving Medical Center have uncovered a crucial structural feature of a key malaria drug target, known as PfATP4, and ...

Coartem Baby, which was already approved for use in patients weighing over 11 pounds, contains artemether and lumefantrine that work together to fight the malaria parasite. HealthDay News — A new ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

A family of parasite proteins could be a promising new malaria drug target. Over 200 million people contract malaria every year; while treatments are available, growing drug resistance remains a ...

For the first time in history, newborns and very young infants have access to a malaria treatment tailored to their unique needs. On July 8, Swissmedic – Switzerland’s regulatory agency – greenlit ...

Malaria kills over 600,000 people a year, and as the climate warms, the potential range of the disease is growing. While some drugs can effectively prevent and treat malaria, resistance to those drugs ...

NEW YORK(AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...